monepantel and albendazole-sulfoxide

monepantel has been researched along with albendazole-sulfoxide* in 1 studies

Trials

1 trial(s) available for monepantel and albendazole-sulfoxide

ArticleYear
Monepantel-based anthelmintic combinations to optimize parasite control in cattle.
    International journal for parasitology, 2023, Volume: 53, Issue:8

    Improvement in the use of existing anthelmintics is a high priority need for the pharmaco-parasitology research field, considering the magnitude and severity of anthelmintic resistance as an important issue in livestock production. In the work described here, monepantel (MNP) was given alone or co-administered with either macrocyclic lactone (ML) or benzimidazole (BZ) anthelmintics to calves naturally infected with ML- and BZ-resistant gastrointestinal (GI) nematodes on two different commercial cattle farms. Both pharmacokinetic (PK) and efficacy assessments were performed. On Farm A, male calves (n = 15 per group) were treated with either MNP orally (2.5 mg/kg), IVM s.c. (0.2 mg/kg), ricobendazole (RBZ) s.c. (3.75 mg/kg) or remained untreated. On Farm B, eight groups (n = 15) of male calves received treatment with either: MNP, abamectin (ABM, oral, 0.2 mg/kg), RBZ (s.c., 3.75 mg/kg), albendazole (ABZ, oral, 5 mg/kg), MNP+ABM, MNP+RBZ, MNP+ABZ (all at the above-mentioned routes and doses) or remained untreated. Seven animals from each treated group (Farm B) were randomly selected to perform the PK study. MNP and its metabolite monepantel sulphone (MNPSO

    Topics: Animals; Anthelmintics; Cattle; Cattle Diseases; Communicable Disease Control; Drug Resistance; Feces; Male; Nematoda; Nematode Infections; Parasite Egg Count

2023